Join the Atrophic Vaginitis group to help and get support from people like you.
Atrophic Vaginitis News (Page 2)
Related terms: Vaginal Atrophy
FDA Approves Osphena (ospemifene) for Moderate to Severe Vaginal Dryness Due to Menopause
BLAINVILLE, QC, January 29, 2019 – Duchesnay Inc., a pharmaceutical company specializing in women’s health, announced today that the FDA has approved its supplemental New Drug Application (sNDA) see...
TherapeuticsMD Announces FDA Approval of Imvexxy (estradiol vaginal inserts) for the Treatment of Dyspareunia Due to Menopause
BOCA RATON, Fla., May 30, 2018 /PRNewswire/ – TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that the United States Food and Drug Administration (FDA)...
FDA Approves Osphena for Postmenopausal Women Experiencing Dyspareunia
February 26, 2013 – The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom...
FDA Approves 10 mcg Dose of Vagifem for the Treatment of Atrophic Vaginitis Due to Menopause
PRINCETON, N.J., Dec. 2 /PRNewswire-FirstCall/ – Novo Nordisk said today that the U.S. Food and Drug Administration (FDA) has approved a 10 mcg dose formulation of Vagifem (estradiol vaginal...
Further information
Related condition support groups
Related drug support groups
Estrace Vaginal Cream, estradiol, Vagifem, Premarin, Estrace